E0 ConsensusModerate confidencePEM unclearMeta-AnalysisPeer-reviewedMachine draft
Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis.
Salari, Nader, Khodayari, Yassaman, Hosseinian-Far, Amin et al. · BioPsychoSocial medicine · 2022 · DOI
Quick Summary
Researchers looked at 52 studies involving over 127,000 people who had recovered from COVID-19 to see how many developed chronic fatigue. They found that about 45% of long COVID patients experienced persistent fatigue lasting at least four weeks after infection. This fatigue can significantly impact daily life, work, and relationships.
Why It Matters
This study quantifies a substantial overlap between long COVID and ME/CFS symptoms, suggesting that post-viral fatigue syndromes may share common pathophysiological mechanisms. The high prevalence (45%) underscores the urgent need for clinical recognition, diagnosis, and research funding to understand and treat post-viral fatigue in both populations.
Observed Findings
- Pooled prevalence of chronic fatigue among long COVID patients was 45.2% (95% CI: 34.1–56.9%) based on 52 studies with 127,117 participants.
- Higher prevalence estimates were observed in studies with smaller sample sizes.
- Prevalence estimates varied by year of publication, suggesting methodological or population differences across studies.
- Fatigue persisted at least 4 weeks after initial COVID-19 symptom onset in nearly half of long COVID cases.
Inferred Conclusions
- Chronic fatigue is among the most common and debilitating symptoms of long COVID syndrome.
- The high prevalence of fatigue in long COVID warrants substantial policy and funding support for affected patients.
- Persistent post-COVID fatigue has significant personal and social consequences requiring clinical and public health intervention.
Remaining Questions
- Do long COVID patients with fatigue meet formal ME/CFS diagnostic criteria (e.g., ICC criteria, Oxford criteria), or do they represent a phenotypically distinct post-viral syndrome?
- What are the underlying biological mechanisms linking SARS-CoV-2 infection to persistent fatigue, and do they differ from ME/CFS pathophysiology?
- What are the long-term trajectories and prognoses of long COVID fatigue, and which patients recover versus develop chronic illness?
What This Study Does Not Prove
This study does not prove that long COVID-related fatigue is identical to ME/CFS or shares the same underlying cause—it only documents symptom overlap. The meta-analysis cannot establish causation or mechanism, nor does it clarify whether COVID-19 triggers ME/CFS in susceptible individuals or produces a distinct post-viral syndrome. Heterogeneity across studies and varying case definitions weaken confidence in the exact prevalence figure.
Tags
Symptom:Fatigue
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:Weak Case DefinitionMixed Cohort
Metadata
- DOI
- 10.1186/s13030-022-00250-5
- PMID
- 36274177
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →